Skip to main content

Table 3 The NOS quality of included studies

From: Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis

Study

Selection

Comparability

Outcome

Total

Quality

 

REC

SNEC

AE

DO

SC

AF

AO

FU

AFU

  

Stahl 2003 [4]

1

1

1

1

0

0

1

0

0

5

Moderate

Mochiki 2004 [14]

1

1

1

1

0

0

0

0

1

5

Moderate

Chung 2010 [23]

1

1

1

1

0

0

0

1

1

6

Moderate

Park 2012 [16]

1

1

1

1

0

0

1

0

0

5

Moderate

Lee 2012 [15]

1

1

1

1

0

0

0

1

1

6

Moderate

Kim 2014 [24]

1

1

1

1

0

0

0

1

1

6

Moderate

Lee 2015 [12]

1

1

1

1

0

0

1

1

0

6

Moderate

Song 2015 [26]

1

1

1

1

0

0

0

1

1

6

Moderate

  1. REC representativeness of the exposed cohort, SNEC selection of the non-exposed cohort, AE ascertainment of exposure, DO demonstration that outcome of interest was not present at start of study, SC study controls for age, sex, AF study controls for any additional factors (chemoradiotherapy, curative resection), AO assessment of outcome, FU follow-up long enough (36 M) for outcomes to occur, AFU adequacy of follow-up of cohorts. “1” means that the study is satisfied the item and “0” means the opposite situation